A biochemical pregnancy is a pregnancy that is detected by a blood or urine hCG test — confirming that implantation has begun and the embryo has produced pregnancy hormone — but which ends before it can be seen on ultrasound, typically before 5–6 weeks of gestation.

In natural conception, the majority of biochemical pregnancies go undetected because they end before a missed period. In IVF, because patients have a blood hCG test precisely 14 days after embryo transfer, biochemical pregnancies are routinely detected and counted. This means that IVF patients experience pregnancy loss that would be invisible in natural conception — a medically important distinction, but one that adds a layer of grief that many patients are not adequately prepared for.

What Happens Clinically

After embryo transfer, the clinic schedules a blood beta-hCG test at approximately 14 days post-transfer. A positive result means the embryo implanted and has been producing hCG. In a continuing pregnancy, hCG doubles approximately every 48–72 hours in the early weeks.

A biochemical pregnancy follows a different pattern:

  • The initial hCG level may be low (below 100 mIU/mL at 14 days post-transfer) or rising slowly
  • On repeat testing (typically 48 hours later), hCG fails to double as expected, rises very slowly, or falls
  • The loss occurs before an intrauterine pregnancy can be confirmed on ultrasound (before approximately 5–6 weeks)
  • Physically, the experience is similar to a late period — cramping and bleeding

Some clinics call at the point of a low initial hCG to prepare patients for the possibility that the result may not progress; others wait for the repeat test before communicating. The clinic's approach to this communication is worth asking about in advance if this is a concern.

Why Biochemical Pregnancies Happen

The most common cause is chromosomal abnormality in the embryo — the same reason most early pregnancy losses occur. An aneuploid embryo can implant and begin producing hCG briefly, but typically arrests early in development before ultrasound visibility.

This is why the rate of biochemical pregnancy per embryo transferred is higher in older patients (where egg aneuploidy rates are higher) and is the rationale for PGT-A (preimplantation genetic testing) in patients with repeated early losses. See preimplantation genetic testing.

Other less common causes include uterine factors, immune factors, or simply the developmental fragility of that particular embryo.

How Common Is It?

Biochemical pregnancies are not rare in IVF. Published rates vary by age and embryo quality, but approximately 10–25% of positive pregnancy tests after IVF do not progress to clinical pregnancy. The rate is higher in older patients and with lower-grade embryos.

This is one of the reasons HFEA success rate reporting distinguishes between "positive pregnancy test rate," "clinical pregnancy rate" (seen on ultrasound), and "live birth rate." Patients sometimes compare their clinic's positive test rate with another clinic's live birth rate without realising these are different measures.

Does a Biochemical Pregnancy Count as a Cycle?

For NHS funding purposes, how a biochemical pregnancy is classified matters. NHS IVF funded cycles are typically counted per embryo transfer — meaning a transfer that resulted in a biochemical pregnancy has "used" one funded cycle, even though no ongoing pregnancy resulted.

Whether this uses one of the NHS-funded cycles is governed by the ICB's specific policy. Some ICBs allow patients who experienced a biochemical pregnancy (or a cancelled transfer) to access their next funded cycle sooner or without it counting as a complete cycle — but this varies. Ask your clinic and ICB directly.

What It Means for Future Cycles

A single biochemical pregnancy does not significantly change the prognosis for subsequent cycles. Implantation occurred — which is clinically encouraging — and the loss was almost certainly embryonic rather than uterine.

If biochemical pregnancies recur (two or more positive tests that do not progress), this begins to overlap with the clinical territory of recurrent implantation failure and early pregnancy loss. At this point, additional investigation is warranted — similar to the approach described in recurrent implantation failure and recurrent miscarriage and IVF.

Relevant questions to raise with your clinic after a biochemical pregnancy:

  • What was the hCG level at 14 days, and how did it trend?
  • What was the grade and quality of the transferred embryo?
  • Was PGT-A discussed, and if not, is it now relevant to consider?
  • Is any additional investigation recommended before the next transfer?

The Emotional Reality

A biochemical pregnancy is a loss. Even though it was very early, the experience of a positive test followed by a negative outcome is grief. Many people feel the loss acutely — not in spite of how early it was, but because of what it briefly represented: evidence that implantation is possible.

The invisibility of biochemical pregnancy in wider social awareness means that most people who experience one do not have access to the social support given to later losses. The Miscarriage Association explicitly recognises biochemical pregnancy as pregnancy loss and provides resources and peer support.

Allowing yourself to grieve — and seeking support from someone who understands — is appropriate and legitimate. See IVF and mental health support for available resources.

Frequently Asked Questions

Q: Is a biochemical pregnancy better or worse than no pregnancy at all?

A: From a clinical perspective, a biochemical pregnancy demonstrates that implantation occurred — which is encouraging information about uterine receptivity. It does not guarantee success in future cycles, but it is not a negative prognostic sign in the way that no implantation at all might be. The emotional reality is more complex — for many patients, a brief positive followed by a loss is harder than a straightforwardly negative test.

Q: Does a biochemical pregnancy mean my uterus is healthy?

A: Implantation occurring suggests the uterine environment allowed the embryo to begin developing. It does not rule out all uterine factors but is generally reassuring about the lining's basic receptivity.

Q: Should I wait before doing another transfer after a biochemical pregnancy?

A: Most clinics recommend waiting one or two natural menstrual cycles before a subsequent FET, to allow the endometrium to recover. In some cases, transfer can be attempted sooner. Discuss the timing with your clinic.

Q: My clinic said my hCG was 15 at 14 days. Is that a biochemical pregnancy?

A: An hCG of 15 mIU/mL at 14 days post-transfer is a low but technically positive result. Whether it will continue depends on the trend over the following 48–72 hours. Your clinic will test again to check whether hCG is rising. A value that low at 14 days has a low probability of resulting in an ongoing clinical pregnancy, but this is not certain until the trend is confirmed.

Q: Is there anything I could have done differently?

A: In almost all cases, no. Biochemical pregnancies are caused by embryo-level events — most commonly chromosomal abnormality — that are not affected by patient behaviour during the two-week wait. Rest, diet, activity restrictions, and stress levels do not cause or prevent biochemical pregnancy loss.

This article is for information only and does not constitute medical advice. If you have experienced a biochemical pregnancy, discuss the implications for your specific treatment plan with your fertility specialist.